# LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapy

> **NCT06885736** · NA · RECRUITING · sponsor: **Dasman Diabetes Institute** · enrollment: 232 (estimated)

## Conditions studied

- Obesity

## Interventions

- **BEHAVIORAL:** Resistance exercise
- **DIETARY_SUPPLEMENT:** Protein Intake

## Key facts

- **NCT ID:** NCT06885736
- **Lead sponsor:** Dasman Diabetes Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-07
- **Primary completion:** 2029-08-30
- **Final completion:** 2029-12-31
- **Target enrollment:** 232 (ESTIMATED)
- **Last updated:** 2026-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06885736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06885736, "LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06885736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*